[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367696-105":59,"doc-detail-367696-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","increased-colorectal-and-endometrial-cancer-rates-in-a-genomically-ascertained-lynch-syndrome-cohort-article-abstract","Increased colorectal and endometrial cancer rates in a genomically ascertained Lynch syndrome cohort - Article abstract","","Background: Lynch syndrome (LS) is a hereditary cancer predisposition that increases risk for colorectal, endometrial, and other cancers, but clinical presentation in genomically ascertained populations is unclear. Methods: Using MyCode’s biobank-linked genomic screening results, adult cases with LS pathogenic/likely pathogenic variants and matched controls without LS risk variants reported personal and family cancer histories. Rates meeting NCCN testing guidelines and cancer incidence in cases, controls, and relatives were calculated and compared. Results: 175 cases and 169 controls showed higher colorectal and endometrial cancer rates in cases and relatives. Conclusions: NCCN guidelines missed many P/LP LS cases, and genomic screening can support risk identification and tailored prevention and early detection.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/increased-colorectal-and-endometrial-cancer-rates-in-a-genomically-ascertained-lynch-syndrome-cohort-article-abstract/367696/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/increased-colorectal-and-endometrial-cancer-rates-in-a-genomically-ascertained-lynch-syndrome-cohort-article-abstract/367696.png","ImageObject",300,407,{"name":92,"@type":93},"Stanford","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is Lynch syndrome and why is it important to identify it?","Question",{"text":112,"@type":113},"Lynch syndrome is a hereditary cancer predisposition caused by mismatch repair gene variants and EPCAM deletions. Identifying people with LS enables medical management changes that can reduce morbidity and mortality and informs at-risk family members.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were cases and controls defined in this study?",{"text":117,"@type":113},"Cases were adult participants with clinically actionable LS pathogenic/likely pathogenic variants returned by the MyCode biobank. Controls were participants without a cancer predisposition variant, matched to cases, and both groups reported personal and family cancer histories.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about cancer rates in cases versus controls?",{"text":121,"@type":113},"Case probands had higher colorectal and endometrial cancer rates than controls, and relatives of cases also showed higher rates than relatives of controls.",{"name":123,"@type":110,"acceptedAnswer":124},"What is the study’s key takeaway about NCCN guidelines and genomic screening?",{"text":125,"@type":113},"NCCN guidelines missed a substantial fraction of LS cases with pathogenic/likely pathogenic variants. Genomic screening can help identify individuals at risk for LS-related cancers to enable tailored risk management and early detection.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},367696,1790471856,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","JNCI Cancer Spectrum, 2025, 9(4), pkaf061  \n[https://doi.org/10.1093/jncics/pkaf061](https://doi.org/10.1093/jncics/pkaf061)  \nAdvance Access Publication Date: June 11, 2025  \nArticle  \nIncreased colorectal and endometrial cancer rates in agenomically ascertained Lynch syndrome cohort  \nMiranda L.G. Hallquist , MSc1, 􀀃 , Juliann M. Savatt , MS1, Kristy Diloreto , MS1, Alicia Johns, PhD2, Amie Decker, MS1, Cameron Hayes, MS1, Melissa A. Kelly , MS1, Henry Lester Kirchner , PhD2, Natasha T. Strande , PhD3,  \nAdam H. Buchanan , MS, MPH1  \n1Department of Genomic Health, Geisinger, Danville, PA, United States 2Department of Population Health Sciences, Geisinger, Danville, PA, United States 3Department of Developmental Medicine, Geisinger, Danville, PA, United States  \n􀀃 Corresponding author: Miranda L. G. Hallquist, MSc, CGC, Department of Genomic Health, Geisinger, 100 N. Academy Ave, Danville, PA 17822, United States ([mhallquist@geisinger.edu](mhallquist@geisinger.edu)) .  \nAbstract  \nBackground: Lynch syndrome (LS) is a hereditary cancer predisposition that increases risk for colorectal, endometrial, and other cancers. Although population-based genomic screening programs identify individuals with LS, clinical presentation in such genomically ascertained populations is unknown.  \nMethods: MyCode is a healthcare system-based biobank that returns clinically actionable genomic screening results to participants, including pathogenic/likely pathogenic (P/LP) variants in LS genes (MLH1, MSH2, MSH6, PMS2) . Adult cases (participants with an LS result) and controls (participants without a cancer predisposition variant matched to cases) reported their personal and family cancer histories. Rates of meeting National Comprehensive Cancer Network (NCCN) genetic testing guidelines and rates of colorectal and endometrial cancers in cases, controls, and their family members were calculated and compared.  \nResults: A total of 175 cases (10 MLH1, 7 MSH2, 83 MSH6, and 75 PMS2) and 169 controls were included. Of case pedigrees, 62/175 (35.4%) met NCCN criteria for LS evaluation. Case pedigrees were more likely (P \u003C .001) to meet criteria than control pedigrees (4/169, 8.35%). Case probands had significantly higher rates of colorectal and endometrial cancer than controls (7.7% vs 2.4%, P ¼ .03 colorectal; 11.5% vs 0%, P \u003C .001 endometrial), as did their relatives (3.1% vs 0.9%, P \u003C .001 colorectal; 2.2% vs 0.5%, P \u003C .001 endometrial) . Conclusions: NCCN guidelines missed 65% of cases with P/LP LS variants despite families having higher colorectal and endometrial cancer rates compared with controls. Genomic screening can assist in identifying individuals at risk for LS-related cancers, providing an opportunity to tailor risk management for cancer prevention and early detection.  \nIntroduction  \nLynch syndrome (LS) is a common, autosomal dominant hereditary cancer syndrome caused by variants in the mismatch repair genes MLH1 , MSH2 , MSH6 , and PMS2 and deletions in EPCAM, affecting an estimated 1 in 279 individuals.1 Individuals with LS are at significantly increased risk of developing colorectal (9% - 61% lifetime risk), endometrial (13%-57% lifetime risk), and other cancers, with variable risks across genes.2-4 Identifying individuals with LS is critical because changes in medical management can lead to a reduction in morbidity and mortality.5 Colonoscopies are a well-established recommendation for primary prevention of colorectal cancer, and risk-reducing hysterectomies are effective at decreasing incidence of endometrial cancer.6-9 For individuals with LS who have a diagnosis of cancer, targeted therapies are available.10 , 11 Identification of LS is important not only for individuals but also for their family members because close genetic relatives may also carry the LS variant and associated increased cancer risks.12  \nLS is identified in two main ways based on clinical presentation (hereafter, “clinically ascertained”) . First, individuals can","cbCaiskw5jyeDy6m","https://ap.wps.com/l/cbCaiskw5jyeDy6m","pdf",1006353,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is Lynch syndrome and why is it important to identify it?\",\"answer\":\"Lynch syndrome is a hereditary cancer predisposition caused by mismatch repair gene variants and EPCAM deletions. Identifying people with LS enables medical management changes that can reduce morbidity and mortality and informs at-risk family members.\"},{\"question\":\"How were cases and controls defined in this study?\",\"answer\":\"Cases were adult participants with clinically actionable LS pathogenic/likely pathogenic variants returned by the MyCode biobank. Controls were participants without a cancer predisposition variant, matched to cases, and both groups reported personal and family cancer histories.\"},{\"question\":\"What did the study find about cancer rates in cases versus controls?\",\"answer\":\"Case probands had higher colorectal and endometrial cancer rates than controls, and relatives of cases also showed higher rates than relatives of controls.\"},{\"question\":\"What is the study’s key takeaway about NCCN guidelines and genomic screening?\",\"answer\":\"NCCN guidelines missed a substantial fraction of LS cases with pathogenic/likely pathogenic variants. Genomic screening can help identify individuals at risk for LS-related cancers to enable tailored risk management and early detection.\"}]","Increased colorectal and endometrial cancer rates in a genomically ascertained Lynch syndrome cohort - Article abstract | PDF",1790172085,23,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c9d1c7e19b1a071c1aec06dadf277cc.webp",983,1291,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ceba2bdb4526af7f92e206a44f973c2e.webp",982,1290,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/553c31b02337a03dc25172cae3f40b42.webp",981,1289,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/923c3d1c31aa2e086784e7b44e706b61.webp",980,1287]